Assessment of clinical usefulness of Eviprostat for benign prostatic hyperplasia--comparison of Eviprostat tablet with a formulation containing two-times more active ingredients

Assessment of clinical usefulness of Eviprostat for benign prostatic hyperplasia--comparison of Eviprostat tablet with a formulation containing two-times more active ingredients

We compared the usefulness of Eviprostat tablet, a therapeutic agent for benign prostatic hyperplasia (BPH), and EVI-F tablet, a new formulation of Eviprostat containing two times more active ingredients (Chimaphila umbellata extract, Populus tremula extract, Pulsatilla pratensis extract, Equisetum...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 54(2008), 6 vom: 07. Juni, Seite 435-45
1. Verfasser: Tamaki, Masahiro (VerfasserIn)
Weitere Verfasser: Nakashima, Masakazu, Nishiyama, Ryuichi, Ikeda, Hiroki, Hiura, Masaru, Kanaoka, Toshio, Nakano, Tadasu, Hayashi, Tadashi, Ogawa, Osamu
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2008
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Comparative Study English Abstract Journal Article Randomized Controlled Trial Drug Combinations Plant Extracts Tablets Ethamsylate 24YL531VOH eviprostat 59738-67-9